Effusion cytology of malignant melanoma: A morphologic and immunocytochemical analysis including application of the MART-1 antibody

Cancer

Volumn 81, Issue 1, 1997, Pages 57-63

  Beaty, Michael W ^a   Fetsch, Patricia ^a   Wilder, Anna Maria ^a   Marincola, Francesco ^a   Abati, Andrea ^a,b  

^a NATIONAL CANCER INSTITUTE   (United States)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

Effusion; Immunocytochemistry; MART 1 antibody; Melanoma; Triage

Indexed keywords

CYTOKERATIN; MELAN A; MEMBRANE ANTIGEN; PROTEIN S 100; UNCLASSIFIED DRUG;

ADENOCARCINOMA; ARTICLE; CELL NUCLEUS; CELL STRUCTURE; CELL VACUOLE; CONTROLLED STUDY; CYTOLOGY; CYTOPLASM; DIAGNOSTIC ACCURACY; DIFFERENTIAL DIAGNOSIS; HUMAN; HUMAN TISSUE; IMMUNOCYTOCHEMISTRY; MELANOMA; MESOTHELIUM CELL; PERITONEUM EXUDATE; PLEURA EFFUSION; PRIORITY JOURNAL; RETROSPECTIVE STUDY;

ADOLESCENT; ADULT; AGED; ANTIBODIES, MONOCLONAL; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; ISOANTIGENS; MALE; MELANOMA; MIDDLE AGED; PLEURAL EFFUSION, MALIGNANT;

EID: 0031585832     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0142(19970225)81:1<57::AID-CNCR12>3.0.CO;2-B     Document Type: Article

References (18)

1. Hajdu SI, Savino A. Cytologic diagnosis of malignant melanoma. Acta Cytol 1973;17:320-7.
2. Nakleh RE, Wick MR, Rocamora A, Swansen PE, Dehner LP. Morphologic diversity in malignant melanomas. Am J Clin Pathol 1990;93:731-40.
3. Niemann TH, Thomas PA. Melanoma with signet-ring cells in a peritoneal effusion. Diagn Cytopathol 1995;12:241-4.
4. Sears D, Hajdu SI. The cytologic diagnosis of malignant neoplasms in pleural and peritoneal effusions. Acta Cytol 1987;31:85-97.
5. Walts AE. Malignant melanoma in effusions: a source of false-negative cytodiagnosis. Diagn Cytopathol 1986;2:150-3.
6. Filho AL, de Carvalho LV, da Cunha Santos G, Oyafuso MS, Lombardo V, Bortolan J, et al. Cytologic diagnosis of melanoma in serous effusions: a morphologic and immunocytochemical study. Acta Cytol 1995;39:481-4.
7. Angeli S, Koelma I, Fleuren GJ, Van Steenis GJ. Malignant melanoma in fine needle aspirates and effusions: an immunocytochemical study using monoclonal antibodies. Acta Cytol 1988;32:707-12.
8. Miettinen M, Franssila K. Immunohistochemical spectrum of malignant melanoma: the common presence of keratins. Lab Invest 1989;61:623-8.
9. Ordonez NG, Sneige N, Hickey RC, Brooks TE. Use of monoclonal antibody HMB-45 in the cytologic diagnosis of melanoma. Acta Cytol 1988;32:684-8.
10. Marincola FM, Hijazi YM, Fetsch P, Salgaller ML, Rivoltini L, Cormier J, et al. Analysis of expression of the melanoma-associated antigens MART-1 and gp100 in metastatic melanoma cell lines and in in situ lesions. J Immunother Emphasis Tumor Immunol 1996;19:192-205.
11. Kawakami Y, Eliyahu S, Sakaguchi K, Robbins PF, Rivoltini L, Yanelli JR, et al. Identification of the immunodominant peptides of the MART-1 human melanoma antigen recognized by the majority of HLA-A2-restricted tumor infiltrating lymphocytes. J Exp Med 1994;180:347-52.
12. Kawakami Y, Eliyahu S, Delgado CH, Robbins PF, Rivoltini L, Topalian SL, et al. Cloning of the gene coding for a shared human melanoma antigen recognized by autologous T-cells infiltrating into tumor. Proc Natl Acad Sci USA 1994;91:3515-9.
13. Kawakami Y, Eliyahu S, Delgado CH, Robbins PF, Sakaguchi K, Appella E, et al. Identification of a human melanoma antigen recognized by tumor infiltrating lymphocytes associated with in-vivo tumor rejection. Proc Natl Acad Sci USA 1994;91:6458-62.
14. Fetsch PA, Kleiner D, Marincola F, Abati A. Analysis of melanoma-associated antigen, MART-1, in normal tissues and in selected non-melanomatous neoplasms [abstract presented at the American and Canadian Academy of Pathology, March 1997, Orlando, Florida.].
15. Fetsch PA, Fetsch J, Travis W, Batts K, Abati A. Comparison of melanoma-associated membrane antigen, MART-1, to HMB-45: further evidence to support a common lineage for angiomyolipoma, lymphangiomyomatosis, and clear cell "sugar tumor" [abstract presented at the American and Canadian Academy of Pathology, March 1997, Orlando, Florida].
16. Fetsch PA, Cormier J, Hijazi YM. Immunocytochemical detection of MART-1 in fresh and paraffin-embedded malignant melanomas. J Immunother Emphasis Tumor Immunol. In press.
17. Bottles K, Reznicek MJ, Holly EA, Ahn DK, Layfield LJ, Cohen MB. Cytologic criteria used to diagnosis adenocarcinoma in pleural effusions. Mod Pathol 1991;4:677-81.
18. Spriggs AI, Grunze H. An unusual cytologic presentation of mesothelioma in serous effusions. Acta Cytol 1983;27:288-92.